Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation

Journal of Vascular Surgery

Volumn 49, Issue 5, 2009, Pages 1217-1225

  Spronk, Sandra ^a   White, John V ^b   Ryjewski, Connie ^b   Rosenblum, Judy ^b   Bosch, Johanna L ^a   Hunink, Myriam G M ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CLAUDICATION; FEMALE; HEART RATE; HEART REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SCORING SYSTEM; TREATMENT INDICATION; TREATMENT OUTCOME; WALKING DIFFICULTY; WALKING IMPAIRMENT QUESTIONNAIRE;

AGED; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEMS, CLINICAL; DISABILITY EVALUATION; FEMALE; HEART RATE; HUMANS; INTERMITTENT CLAUDICATION; LOGISTIC MODELS; MALE; MARKOV CHAINS; MOBILITY LIMITATION; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASES; RECOVERY OF FUNCTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT FAILURE; VASCULAR SURGICAL PROCEDURES; WALKING;

EID: 64949179795     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.11.066     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention, and National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) (2005). http://www.cdc.gov/ncipc/wisqars Accessed: Jun 2, 2008
2. Centers for Disease Control and Prevention. Receipt of outpatient cardiac rehabilitation among heart attack survivors-Unites States, 2005. MMWR 57 (2008) 89-94
3. Suaya J.A., Shepard D.S., Normand S.L., Ades P.A., Prottas J., and Stason W.B. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary artery bypass surgery. Circulation 116 (2007) 1653-1662
4. Wenger N.K. Current status of cardiac rehabilitation. J Am Coll Cardiol 51 (2008) 1619-1631
5. Adams B.J., Carr J.G., Ozonoff A., Lauer M.S., and Balady G.J. Effect of exercise training in supervised cardiac rehabilitation programs on prognostic variables from the exercise tolerance test. Am J Cardiol 101 (2008) 1403-1407
6. Haykowsky M.J., Liang Y., Pechter D., Jones L.W., McAlister F.A., and Clark A.M. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Caridol 49 (2007) 2329-2336
7. Lavie C.J., and Milani R.V. Benefits of cardiac rehabilitation and exercise training programs in elderly coronary patients. Am J Geriatr Cardiol 10 (2001) 323-327
8. Jolliffe J.A., Rees K., Taylor R.S., Thompson D., Oldridge N., and Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2001) CD001800
9. Thompson P.D. Exercise prescription and proscription for patients with coronary artery disease. Circulation 112 (2005) 2354-2363
10. Taylor R.S., Brown A., Ebrahim S., Jolliffe J., Noorani H., Rees K., et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116 (2004) 682-692
11. Quell K.J., Porcari J.P., Franklin B.A., Foster C., Andreuzzi R.A., and Anthony R.M. Is brisk walking an adequate aerobic training stimulus for cardiac patients?. Chest 122 (2002) 1852-1856
12. Franklin BA, deJong AT. Exercise prescription. In: American Association of Cardiovascular and Pulmonary Rehabilitation Cardiac Rehabilitation Resource Manual. 4th ed. p. 75-82.
13. Kavanagh T., Hamm L.F., Beyene J., Mertens D.J., Kennedy J., Campbell R., et al. Usefulness of improvement in walking distance versus peak oxygen uptake in predicting prognosis after myocardial infarction and/or coronary artery bypass grafting in men. Am J Cardiol 101 (2008) 1423-1427
14. Cronenwett J.L., Warner K.G., Zelenock G.B., Whitehouse Jr. W.M., Graham L.M., Lindenauer M., et al. Intermittent claudication: current results of nonoperative management. Arch Surg 119 (1984) 430-436
15. Rutherford R.B., and Dormandy J.A. Management of peripheral arterial disease: TransAtlantic Inter-Society Consensus. J Vasc Surg 31 (2000) S18-S20
16. Muluk S.C., Muluk V.S., Kelley M.E., Whittle J.C., Tierney J.A., Webster M.W., et al. Outcome events in patients with caludication: a 15-year study in 2777 patients. J Vasc Surg 33 (2001) 251-258
17. Rockson S.G., and Cooke J.P. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Int Med 43 (1998) 253-277
18. Pollock M.L., and Gomes P.S. Exercise prescription: with and without exercise testing. In: Wenger N.K., Smith E., Froelicher E., and Comoss P. (Eds). Cardiac rehabilitation: guide to procedures for the 21st century (1999), Marcel Dekker, New York 49-66
19. Rutherford R.B., and Dormandy J.A. Management of peripheral arterial disease: TransAtlantic Inter-Society Consensus. J Vasc Surg 31 (2000) S69
20. Coyne K.S., Margolis M.K., Gilchrist K.A., Grandy S.P., Hiatt W.R., Ratchford A., et al. Evaluating effect of method of administration on Walking Impairment Questionnaire. J Vasc Surg 38 (2003) 296-304
21. McDermott M.M., Liu K., Guralnik J.M., Martin G.J., Criqui M.H., and Greenland P. Measurement of Walking Impairment Questionnaire in men and women with peripheral arterial disease. J Vasc Surg 28 (1998) 1072-1081
22. McDermott M.M., Kerwin D.R., Liu K., Martin G.J., O'Brien E., Kaplan H., and Greenland P. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med 16 (2001) 384-390
23. Karvonen M., Kentala K., and Mustala O. The effects of training heart rate: A longitudinal study. Ann Med Exp Biol 35 (1957) 307-315
24. Sonnenberg F.A., and Beck J.R. Markov models in medical decision making: a practical guide. Med Decis Making 133 (1993) 22-38
25. st ed. (2001), C.U. Press, Cambridge
26. Data Warehouse, National Center for Health Statistics (2006). http://www.cdc.gov/nchs/datawh/statab/unpubd/mortabs.htm
27. Poredos P., and Jug B. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 58 (2007) 309-315
28. de Vries S.O., Visser K., de Vries J.A., Wong J.B., Donaldson M.C., and Hunink M.G. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 222 (2002) 25-36
29. Bergqvist D., Troeng T., Elfstrom J., Hedberg B., Ljungstrom K.G., Norgren L., et al. Auditing surgical outcome: ten years with the Swedish Vascular Registry-Swedvasc. The Steering Committee of Swedvasc. Eur J Surg Suppl (1998) 3-8
30. Bosch J.L., van der Graaf Y., and Hunink M.G. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation 99 (1999) 3155-3160
31. Hunink M.G., Wong J.B., Donaldson M.C., Meyerovitz M.F., and Harrington D.P. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 14 (1994) 71-81
32. Chang R.W., Goodney P.P., Baek J.H., Nolan B.W., Rzucidlo E.M., and Powel R.J. Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 48 (2008) 362-367
33. Bosch J.L., Tetteroo E., Mali W.P., and Hunink M.G. Iliac artery occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiology 208 (1998) 641-648
34. Murphy T.P., Ariaratnam N.S., Carney Jr. W.I., Marcaccio E.J., Slaiby J.M., Soares G.M., et al. Aortoiliac insufficiency: long-term experience with stent placement for treatment. Radiology 231 (2004) 243-249
35. DeRubertis B.G., Faries P.L., McKinsey J.F., Chaer R.A., Pierce M., Karwowski J., et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg 246 (2007) 415-422 discussion 422-4
36. Scott E.C., Biuckians A., Light R.E., Burgess J., Meier III G.H., and Panneton J.M. Subintimal angioplasty: our experience in the treatment of 506 infrainguinal arterial occlusions. J Vasc Surg 48 (2008) 878-884
37. Reed A.B., Conte M.S., Donaldson M.C., Mannick J.A., Whittemore A.D., and Belkin M. The impact of patient age and aortic size on the results of aortobifemoral grafting. J Vasc Surg 37 (2003) 1219-1225
38. Davidovic L., Vasic D., Maksimovic R., Kostic D., Markovic D., and Markovic M. Aortobifemoral grafting: factors influencing long-term results. Vascular 12 (2004) 171-178
39. Schanzer A., Hevelone N., Owens C.D., Beckman J.A., Belkin M., and Conte M.S. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg 47 (2008) 744-781
40. Hessel S.J., Adams D.F., and Abrams H.L. Complications of angiography. Radiology 138 (1981) 273-281
41. Waugh J.R., and Sacharias N. Arteriographic complications in the DSA era. Radiology 182 (1999) 243-246
42. Conrad M.F., Cambria R.P., Stone D.H., Brewster D.C., Kwolek C.J., Watkins M.T., et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 44 (2006) 762-769
43. Hunink M.G., Wong J.B., Donaldson M.C., Meyerovitz M.F., de Vries J., and Harrington D.P. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 274 (1995) 165-171
44. Bosch J.L., and Hunink M.G. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 204 (1997) 87-96
45. Muradin G.S., Bosch J.L., Stijnen T., and Hunink M.G. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221 (2001) 137-145
46. Gentile A.T., Lee R.W., Moneta G.L., Taylor L.M., Edwards J.M., and Porter J.M. Results of bypass to the popliteal and tibial arteries with alternative sources of autogenous vein. J Vasc Surg 23 (1996) 272-279 discussion 279-80
47. Green R.M., Abbott W.M., Matsumoto T., Wheeler J.R., Miller N., Veith F.J., et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 31 (2000) 417-425
48. Johnson W.C., and Lee K.K. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32 (2000) 268-277
49. Albers M., Battistella V.M., Romiti M., Rodrigues A.A., and Pereira C.A. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 37 (2003) 1263-1269
50. Tetteroo E., van der Graaf Y., Bosch J.L., van Engelen A.D., Hunink M.G., Eikelboom B.C., et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 351 (1998) 1153-1159
51. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 1 Suppl (2007) S5-S67
52. Kavanagh T., Hamm L.F., Beyene J., Mertens D.J., Kennedy J., Campbell R., et al. Usefulness of improvement in walking distance versus peak oxygen uptake in predicting prognosis after myocardial infarction and/or coronary artery bypass grafting in men. Am J Cardiol 101 (2008) 1423-1427
53. Myers S.A., Johanning J.M., Stergiou N., Lynch T.G., Longo G.M., and Pipinos I.I. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease. J Vasc Surg 47 (2008) 500-505
54. Murphy T.P., Soares G.M., Kim H.M., Ahn S.H., and Haas R.A. Quality of life and exercise performance after aortoiliac stent placement for claudication. J Vasc Interv Radiol 16 (2005) 947-953
55. Nylaende M., Abdelnoor M., Stranden E., Morken B., Sandbaek G., Risum O., et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT)-the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg 33 (2007) 3-12